A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer

BMC Molecular Biology

Volumn 3, Issue , 2002, Pages

  Lefesvre, Pierre ^a   Attema, Joline ^a   van Bekkum, Dirk ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LUCIFERASE; NAKED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA TRANSFER; ELECTROPORATION; GENETIC CODE; GENETIC TRANSFECTION; LIVER INJURY; MAST CELL; MOUSE; MUSCLE INJURY; NONHUMAN; PLASMID; RAT; RHABDOMYOLYSIS; SAFETY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

EID: 0042812244     PISSN: 14712199     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2199-3-12     Document Type: Article

References (30)

1. Alemany R, Curiel DT: CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 2001, 8:1347-1353
2. Paielli DL, Wing MS, Rogulski KR, Gilbert JD, Kolozsvary A, Kim JH, Hughes J, Schnell M, Thompson T, Freytag SO: Evaluation of the biodistribution, persistence, toxicity, and potential of germline transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse. Mol Ther 2000, 1:263-274
3. Leissner P, Legrand V, Schlesinger Y, Hadji DA, van Raaij M, Cusack S, Pavirani A, Mehtali M: Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther 2001, 8:49-57
4. Vos A, Neubert A, Pommerening E, Muller T, Dohner L, Neubert L, Hughes K: Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J Gen Virol 2001, 82:2191-2197
5. Christ M, Louis B, Stoeckel F, Dieterle A, Grave L, Dreyer D, Kintz J, Ali Hadji D, Lusky M, Mehtali M: Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum Gene Ther 2000, 11:415-427
6. Ji L, Bouvet M, Price RE, Roth JA, Fang B: Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement. Gene Ther 1999, 6:393-402
7. Hauser MA, Robinson A, Hartigan-O'Connor D, Williams-Gregory DA, Buskin JN, Apone S, Kirk CJ, Hardy S, Hauschka SD, Chamberlain JS: Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. Mol Ther 2000, 2:16-25
8. Bettan M, Emmanuel F, Darteil R, Caillaud JM, Soubrier F, Delaere P, Branelec D, Mahfoudi A, Duverger N, Scherman D: High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther 2000, 2:204-210
9. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D: High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 1999, 96:4262-4267
10. Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D: Longterm, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998, 321:893-899
11. Lohr F, Lo DY, Zaharoff DA, Hu K, Zhang X, Li Y, Zhao Y, Dewhirst MW, Yuan F, Li CY: Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res 2001, 61:3281-3284
12. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW: Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 2000, 7:541-547
13. Smith LC, Nordstrom JL: Advances in plasmid gene delivery and expression in skeletal muscle. Curr Opin Mol Ther 2000, 2:150-154
14. Tamura T, Nishi T, Goto T, Takeshima H, Dev SB, Ushio Y, Sakata T: Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Hum Gene Ther 2001, 12:1265-1276
15. Yang Y, Haecker SE, Su Q, Wilson JM: Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996, 5:1703-1712
16. Adam E, Nasz I: [In Process Citation]. Orv Hetil 2001, 142:2061-2070
17. Gehl J, Mir LM: Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999, 261:377-380
18. Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, Mir LM: In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999, 1428:233-240
19. Block TA, Aarsvold JN, Matthews KL 2nd, Mintzer RA, River LP, Capelli-Schellpfeffer M, Wollmann RL, Tripathi S, Chen CT, Lee RC: The 1995 Lindberg Award. Nonthermally mediated muscle injury and necrosis in electrical trauma. J Burn Care Rehabil 1995, 16:581-588
20. Lee RC, Zhang D, Hannig J: Biophysical injury mechanisms in electrical shock trauma. Annu Rev Biomed Eng 2000, 2:477-509
21. Morita M, Kaneko M, Onodera K, Mizuguchi M, Ohtani S: [A histological study of striated muscle and nerve fiber in the human caused by a high voltage electric current]. Nippon Hoigaku Zasshi 1989, 43:40-45
22. Bureau MF, Gehl J, Deleuze VV, Mir LM, Scherman D: Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000, 1474:353-359
23. Esandi MC, Verlinden SFF, Vries de MW, Pfeffer G, Bekkum van DW: Neutralizing antibodies against Adeno 5 virus open the therapeutic window for interleukin-3 gene therapy of tumors with adenovirus 5 based vectors. submitted to gene therapy 2001
24. Lamfers ML, Lardenoye JH, de Vries MR, Aalders MC, Engelse MA, Grimbergen JM, van Hinsbergh VW, Quax PH: In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI. Gene Ther 2001, 8:534-541
25. Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC: New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998, 9:1909-1917
26. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ: Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996, 7:215-222
27. Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S: Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 1997, 8:453-465
28. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
29. Kal HB, Meijnders PJ, Van Berkel AH, Van Bekkum DW: Response to chemotherapy of non-small cell bronchial rat tumours growing subcutaneously or in the lung. In Vivo 1991, 5:301-306
30. Esandi MC, van Someren GD, Bout A, Mulder AH, van Bekkum DW, Valerio D, Noteboom JL: IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using 'cracked' adenoproducer cells. Gene Ther 1998, 5:778-788